In vivo experimental results manifested that knockdown of miR-155-5p strengthened the anticancer activity of cetuximab in an EGFR-overexpressing TNBC xenograft mouse model by prompting cancer cell pyroptosis. The gene discussed is EGFR; the disease is cancer.